LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to:
- The Use of LDN and Amino Acids in Parkinson’s Disease Ted Cole, DO
- LDN, Neuroinflammation and Movement Disorders Mark Cooper, PhD
- LDN and Memory Loss Pamela Smith, MD
- Sleep - PTSD HPA Axis Dysregulation - LDN & The Gut-Brain Barrier Elissa Mullen, ND
- “Just Try LDN”: 3 years of insight from over 1,000 Patients use of Low Dose Naltrexone Sarah Zeildorf, MD, MS
- LDN, Pain and Immunity Steve Ottersberg, MS
- LDN - Key Ingredient in the Biomedical Treatment of Autism Spectrum Disorder Brian Udell, MD